The effect of uremia and hemodialysis on caspase-1 and caspase-3 activity in neutrophils

Journal of Nephrology

Volumn 23, Issue 4, 2010, Pages 425-430

  Korzeniewska Dyl, Irmina ^a   Wróblewski, Krzysztof ^a   Majewska, Ewa ^a   Moczulski, Dariusz ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Caspases; Hemodialysis; Neutrophils; Uremia

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CASPASE 2; CHOLESTEROL; CUPROPHANE; INTERLEUKIN 1BETA CONVERTING ENZYME; PARATHYROID HORMONE; POLYSULFONE; PREALBUMIN; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN; CASPASE 3;

ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; APOPTOSIS; ARTICLE; ARTIFICIAL KIDNEY; BIOCOMPATIBILITY; CELL SURVIVAL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; INFLAMMATION; MALE; NEUTROPHIL; NUTRITION; PARATHYROID HORMONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; TRANSFERRIN BLOOD LEVEL; UREMIA; BLOOD; ENZYMOLOGY; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

CASPASE 1; CASPASE 3; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; PARATHYROID HORMONE; RENAL DIALYSIS; UREMIA;

EID: 77955459541     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Cendoroglo M, Jaber BL, Balakrishnan VS, Perianayagam M, King AJ, Pereira BJ. Neutrophil apoptosis and dysfunction in uremia. J Am Soc Nephrol. 1999;10:93-100.
2. Whyte MK, Meagher LC, MacDermot J, Haslett C. Impairment of function in aging neutrophils is associated with apoptosis. J Immunol. 1993;150:5124-5134.
3. Sela S, Shurtz-Swirski R, Cohen-Mazor M, et al. Primed peripheral polymorphonuclear leukocyte: a culprit underlying chronic low-grade inflammation and systemic oxidative stress in chronic kidney disease. J Am Soc Nephrol. 2005;16:2431-2438.
4. Stenvinkel P, Heimburger O, Lindholm B, Kaysen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant. 2000;15:953-960. (Pubitemid 30410364)
5. Stenvinkel P, Heimburger O, Paultre F, et al. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int. 1999;55:1899-1911.
6. Salvesen GS, Dixit VM. Caspases: intracellular signaling by proteolysis. Cell. 1997;91:443-446.
7. Wolf BB, Green DR. Suicidal tendencies: apoptotic cell death by caspase family proteinases. J Biol Chem. 1999;274:20049-20052. (Pubitemid 129519463)
8. Malyak M, Smith MF Jr, Abel AA, Arend WP. Peripheral blood neutrophil production of interleukin-1 receptor antagonist and interleukin-1 beta. J Clin Immunol. 1994;14:20-30.
9. Tiku K, Tiku ML, Skosey JL. Interleukin 1 production by human polymorphonuclear neutrophils. J Immunol. 1986;136:3677-3685. (Pubitemid 16122063)
10. Thornberry NA, Bull HG, Calaycay JR, et al. A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature. 1992;356:768-774.
11. Fadeel B, Ahlin A, Henter JI, Orrenius S, Hampton MB. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood. 1998;92:4808-4818.
12. Giudice ED, Ciaramella A, Balestro N, et al. Neutrophil apoptosis in autoimmune Fas-defective MRL lpr/lpr mice. Eur Cytokine Netw. 2001;12:510-517.
13. Watson RW, O'Neill A, Brannigan AE, et al. Regulation of Fas antibody induced neutrophil apoptosis is both caspase and mitochondrial dependent. FEBS Lett. 1999;453:67-71.
14. Bahlmann FH, De Groot K, Spandau JM, et al. Erythro- poietin regulates endothelial progenitor cells. Blood. 2004;103:921-926.
15. Parsa CJ, Matsumoto A, Kim J, et al. A novel protective effect of erythropoietin in the infarcted heart. J Clin Invest. 2003;112:999-1007. (Pubitemid 38056315)
16. Pfeilschifter J, Huwiler A. Erythropoietin is more than just a promoter of erythropoiesis. J Am Soc Nephrol. 2004;15:2240-2241.
17. Zeman K, Tchórzewski H, Majewska E, Pokoca L, Pińkowski R. Simple and fast method of simultaneous isolation of highly purified lymphocytes and neutrophils from the peripheral blood. Immunologia Polska. 1988;3-4:217-224.
18. Jaber BL, Perianayagam MC, Balakrishnan VS, King AJ, Pereira BJ. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system. J Leukoc Biol. 2001;69:1006-1012.
19. Majewska E, Baj Z, Sułowska Z, Rysz J, Luciak M. Effects of uraemia and haemodialysis on neutrophil apoptosis and expression of apoptosis-related proteins. Nephrol Dial Transplant. 2003;18:2582-2588.
20. Rowe SJ, Allen L, Ridger VC, Hellewell PG, Whyte MK. Caspase-1-deficient mice have delayed neutrophil apoptosis and a prolonged inflammatory response to lipopolysaccharide-induced acute lung injury. J Immunol. 2002;169:6401-6407.
21. Zhang B, Hirahashi J, Cullere X, Mayadas TN. Elucidation of molecular events leading to neutrophil apoptosis following phagocytosis: cross-talk between caspase 8, reactive oxygen species, and MAPK/ERK activation. J Biol Chem. 2003;278:28443-28454.
22. Watson RW, Rotstein OD, Parodo J, Bitar R, Marshall JC. The IL-1 beta-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1 beta. J Immunol. 1998;161:957-962.
23. Brannigan AE, O'Connell PR, Hurley H, et al. Neutrophil apoptosis is delayed in patients with inflammatory bowel disease. Shock. 2000;13:361-366.
24. Kettritz R, Gaido ML, Haller H, Luft FC, Jennette CJ, Falk RJ. Interleukin-8 delays spontaneous and tumor necrosis factor-alpha- mediated apoptosis of human neutrophils. Kidney Int. 1998;53:84-91. (Pubitemid 28066906)
25. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80:2012-2020.
26. Lee A, Whyte MK, Haslett C. Inhibition of apoptosis and 26. prolongation of neutrophil functional longevity by inflammatory mediators. J Leukoc Biol. 1993;54:283-288.
27. Martin-Malo A, Carracedo J, Ramirez R, et al. Effect of uremia and dialysis modality on mononuclear cell apoptosis. J Am Soc Nephrol. 2000;11:936-942.
28. Hakim RM, Fearon DT, Lazarus JM. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int. 1984;26:194-200.
29. Perianayagam MC, Balakrishnan VS, King AJ, Pereira BJ, Jaber BL. C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int. 2002;61:456-463.
30. Jaber BL, Cendoroglo MN, Balakrishnan VS, Perianayagam MC, King AJ, Pereira BJ. Modulation of neutrophil apoptosis by uremic plasma during hemodialysis. Blood Purif. 1998;16:325-335. (Pubitemid 29237630)
31. van Ypersele de Strihou C. Are biocompatible membranes superior for hemodialysis therapy? Kidney Int Suppl. 1997;62:S101-S104.
32. Agodoa LY, Eggers PW. Renal replacement therapy in the United States: data from the United States Renal Data System. Am J Kidney Dis. 1995;25:119-133.
33. Chertow GM, Ackert K, Lew NL, Lazarus JM, Lowrie EG. Prealbumin is as important as albumin in the nutritional assessment of hemodialysis patients. Kidney Int. 2000;58:2512-2517.
34. Panichi V, Migliori M, De Pietro S, et al. The link of biocompatibility to cytokine production. Kidney Int Suppl. 2000;76:S96-S103.
35. Bagnis C, Beaufils H, Jacquiaud C, et al. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Nephrol Dial Transplant. 2001;16:932-938.
36. Yang CW, Li C, Jung JY, et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J. 2003;17:1754-1755.